^
Association details:
| Biomarker: | NR4A1 overexpression |
|---|---|
| Cancer: | Colon Cancer |
| Drug: | OSI-930 (c-KIT inhibitor, VEGFR-2 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
NR4A1 as a potential therapeutic target in colon adenocarcinoma: a computational analysis of immune infiltration and drug response
Published date:
08/11/2023
Excerpt:
Using cancer therapeutics response analysis, we found that high expression levels of NR4A1 were sensitive to OSI-930, a tyrosine kinase inhibitor with anti-tumor effects.
DOI:
10.3389/fgene.2023.1181320
